Do Managed Entry Agreements Contribute to Lower Pharmaceutical Spending?

被引：1
|
作者：
Vokinger, Kerstin N. [1 ,2 ]
机构：
[1] Univ Zurich, Fac Law, Ramistr 74, CH-8001 Zurich, Switzerland
[2] Univ Zurich, Fac Med, Ramistr 74, CH-8001 Zurich, Switzerland
来源：
JAMA HEALTH FORUM | 2023年 / 4卷 / 12期
关键词：
D O I：
10.1001/jamahealthforum.2023.4610
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Confidentiality in the Pharmaceutical Managed Entry Agreements in Romania
    Paveliu, Marian S.
    Radu, Ciprian P.
    Pana, Bogdan C.
    [J]. ROMANIAN JOURNAL OF MILITARY MEDICINE, 2024, 127 (03) : 222 - 227
  • [2] The impact of managed entry agreements on pharmaceutical prices
    Gamba, Simona
    Pertile, Paolo
    Vogler, Sabine
    [J]. HEALTH ECONOMICS, 2020, 29 : 47 - 62
  • [3] How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
    Shobeiri, Nikta
    Peiravian, Farzad
    Yousefi, Nazila
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
  • [4] Managed entry agreements
    Luisa AA Muscolo
    Claudia Bernardini
    Paolo D Siviero
    Simona Montilla
    Luca Pani
    [J]. Orphanet Journal of Rare Diseases, 9 (Suppl 1)
  • [5] Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
    Jommi, Claudio
    Bertolani, Arianna
    Armeni, Patrizio
    Costa, Francesco
    Otto, Monica
    [J]. HEALTH POLICY AND TECHNOLOGY, 2023, 12 (03)
  • [6] Managed entry agreements for pharmaceuticals in Australia
    Vitry, Agnes
    Roughead, Elizabeth
    [J]. HEALTH POLICY, 2014, 117 (03) : 345 - 352
  • [7] MANAGED ENTRY AGREEMENTS: PORTUGUESE EXPERIENCE
    Goncalves, L.
    Teixeira, M.
    Caldeira, S.
    Ramos, R.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A500 - A500
  • [8] CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS IN AUSTRALIA
    Robinson, Maxine F.
    Mihalopoulos, Cathrine
    Merlin, Tracy
    Roughead, Elizabeth
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (01) : 46 - 55
  • [9] ROMANIAN EXPERIENCE WITH MANAGED ENTRY AGREEMENTS FOR DRUGS
    Radu, P.
    Stoica, I
    Udroiu, P.
    [J]. VALUE IN HEALTH, 2018, 21 : S210 - S211
  • [10] MEDICAL DEVICES MANAGED ENTRY AGREEMENTS IN FRANCE
    Nguyen-Marzin, M.
    Carval, G.
    Zaccherini, T.
    Rumeau-Pichon, C.
    Bouyoux, P.
    de Joannis, P. E.
    [J]. VALUE IN HEALTH, 2020, 23 : S578 - S578
12345